Filing Details

Accession Number:
0001123292-19-000085
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-04 18:47:47
Reporting Period:
2019-01-02
Accepted Time:
2019-01-04 18:47:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1356090 Intrexon Corp XON Services-Commercial Physical & Biological Research (8731) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1583188 D. Thomas Reed 20374 Seneca Meadows Parkway
Germantown MD 20876
Chief Science Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-01-02 9,766 $0.00 82,481 No 4 M Direct
Common Stock Disposition 2019-01-03 2,944 $7.07 79,537 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2019-01-02 9,766 $0.00 9,766 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
29,297 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of XON common stock.
  2. This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units.
  3. The restricted stock units were granted on January 2, 2018, and the remaining restricted stock units vest in three equal annual installments on each of January 2, 2020, 2021 and 2022.